New combo attack on advanced prostate cancer: drugs plus ultrasound
NCT ID NCT07172685
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study is for men with a certain type of advanced prostate cancer that has spread to many places in the body. It tests a treatment plan that combines hormone therapy, a drug called darolutamide, chemotherapy, and a focused ultrasound procedure on the prostate. The goal is to see if this combination can control the cancer longer. About 116 men will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Qilu hospital
RECRUITINGJinan, Shandong, 276600, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.